Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-06-25

Clinical Trial Update: New Hypo-Osmolar ORS (Recommended by WHO) for Routine Use in the Diarrhea Management- Surveillance Study for Adverse Effects [Phase 4]

View source ↗

Summary

Phase 4 study of a hypo-osmolar oral rehydration solution for routine diarrhea management, aligned with WHO recommendations, with surveillance for adverse effec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hypo-Osmolar Oral Rehydration Solution (Oral rehydration solution (hypo-osmolar formulation))

Snippet

Sponsor: Society for Applied Studies | Conditions: Diarrhea, Dysentery | Phase 4 | Status: COMPLETED